No abstract available
Publication types
-
Historical Article
-
Comment
MeSH terms
-
Alemtuzumab
-
Animals
-
Antibodies, Monoclonal / history*
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal / toxicity
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Murine-Derived
-
Antibodies, Neoplasm / therapeutic use
-
Antineoplastic Agents / history
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Agents / toxicity
-
Bevacizumab
-
Disease Models, Animal
-
Forecasting
-
History, 20th Century
-
Humans
-
Immunotherapy / trends
-
Neoplasms / drug therapy*
-
Rituximab
-
Trastuzumab
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Murine-Derived
-
Antibodies, Neoplasm
-
Antineoplastic Agents
-
Bevacizumab
-
Alemtuzumab
-
Rituximab
-
Trastuzumab